The SWENOTECA ABC-study

March 25, 2015

The SWENOTECA now starts inclusion in the ABC-study. This is a randomized phase III study in stage I seminomatous testicular cancer. Patients with one or two risk factors (stromal invasion of the rete testis and/or tumor size over 4 cm) will be randomized between one course of adjuvant carboplatin (AUC7) or one course of standard BEP.  

 

The ABC-study

Please reload

Featured Posts

Kjære SWENOTECA venner. Endelig program og invitasjon for årets stormøte er vedlagt. Møtet er på Gardermoen torsdag 4. april. Påmeldingsfrist er 19. m...

Annual meeting 2019

March 1, 2019

1/5
Please reload

Recent Posts

March 30, 2020

March 1, 2019

October 30, 2015

April 9, 2015

Please reload

Archive
Please reload

Search By Tags
Please reload

​​​Contact Us

SWENOTECA

Kreftklinikken, St. Olavs Hospital,

Postboks 3250 Sluppen

7006 Trondheim, Norway

Follow Us

  • w-facebook

swenoteca.org

 © 2015 SWENOTECA